» Articles » PMID: 33888992

3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2021 Apr 23
PMID 33888992
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Circulating tumor cells (CTCs) are considered to be a key factor involved in tumor metastasis. However, the isolation and culture of CTCs in vitro remains challenging, and their clinical application for predicting prognosis and survival is still limited. The development of accurate evaluating system for CTCs will benefit for clinical assessment of HCC.

Methods: Density gradient centrifugation and magnetic separation based on CD45 antibody were used to isolate CTCs. 3D culture was used to maintain and amplify CTCs and HCC cells. Cellular immunofluorescence was used to identify CTCs and spheroids. The cutoff value of CTC spheroid was calculated using X-tile software. The relationship between clinicopathological variables and CTC spheroids in HCC patients is analyzed. In vivo models were used to evaluate tumor growth and metastasis of CTC spheroids.

Results: Patient-derived CTCs/HCC cells were isolated and expanded to form spheroids using 3D culture. CTC spheroids could be used to predict short-term recurrence of CTCs compared with conventional CTC enumeration. Different cell lines exhibited different formation rates and grew to different sizes. Identification of CTC spheroids revealed that EpCAM and β-catenin were expressed in spheroids derived from HCC cells and in the HCC/CTCs. EpCAM-positive HCC cells exhibited improved spheroid formation in 3D culture and were more tumorigenic and likely to metastasize to the lung in vivo. Abnormal activation of the Wnt/β-catenin signaling pathway was observed in EpCAM positive cells.

Conclusion: CTC spheroids could predict prognosis of HCC more precisely compared with conventional CTC enumeration. EpCAM may participate in the formation and survival of CTC spheroids which dependent on Wnt/β-catenin signaling pathway.

Citing Articles

Superhydrophobic Array Devices for the Enhanced Formation of 3D Cancer Models.

Lopez-Cavestany M, Wright O, Reckhorn N, Carter A, Jayawardana K, Nguyen T ACS Nano. 2024; 18(34):23637-23654.

PMID: 39150223 PMC: 11363216. DOI: 10.1021/acsnano.4c08132.


The Utilization of Optically Induced Dielectrophoresis (ODEP)-Based Cell Manipulation in a Microfluidic System for the Purification and Sorting of Circulating Tumor Cells (CTCs) with Different Sizes.

Chu P, Nguyen T, Wu A, Huang P, Huang K, Liao C Micromachines (Basel). 2023; 14(12).

PMID: 38138338 PMC: 10745986. DOI: 10.3390/mi14122170.


Polyglycerol-Based Biomedical Matrix for Immunomagnetic Circulating Tumor Cell Isolation and Their Expansion into Tumor Spheroids for Drug Screening.

Tang P, Thongrom B, Arora S, Haag R Adv Healthc Mater. 2023; 12(26):e2300842.

PMID: 37402278 PMC: 11469197. DOI: 10.1002/adhm.202300842.


Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells.

Stickler S, Rath B, Hochmair M, Lang C, Weigl L, Hamilton G Oncol Res. 2023; 31(1):13-22.

PMID: 37303738 PMC: 10207976. DOI: 10.32604/or.2022.027281.


Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers.

Rozenberg J, Buzdin A, Mohammad T, Rakitina O, Didych D, Pleshkan V Front Immunol. 2023; 14:1099921.

PMID: 37006265 PMC: 10050392. DOI: 10.3389/fimmu.2023.1099921.


References
1.
Sun B, Hu C, Yang Z, Zhang X, Zhao L, Xiong J . Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. Oncotarget. 2017; 8(20):32523-32535. PMC: 5464806. DOI: 10.18632/oncotarget.15808. View

2.
Zhong X, Zhang H, Zhu Y, Liang Y, Yuan Z, Li J . Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy. Mol Cancer. 2020; 19(1):15. PMC: 6982393. DOI: 10.1186/s12943-020-1141-9. View

3.
Yang J, Campion M, Liu M, Chaiteerakij R, Giama N, Ahmed Mohammed H . Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma. Hepatology. 2015; 63(1):148-58. PMC: 4684812. DOI: 10.1002/hep.27944. View

4.
Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B . Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007; 13(3):920-8. DOI: 10.1158/1078-0432.CCR-06-1695. View

5.
Osta W, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun Y . EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004; 64(16):5818-24. DOI: 10.1158/0008-5472.CAN-04-0754. View